Pacific Biosciences
PACB
PACB
155 hedge funds and large institutions have $809M invested in Pacific Biosciences in 2018 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
37% more capital invested
Capital invested by funds: $590M → $809M (+$220M)
31% more funds holding
Funds holding: 118 → 155 (+37)
1.4% less ownership
Funds ownership: 74.5% → 73.1% (-1.4%)
Holders
155
Holding in Top 10
3
Calls
$8.75M
Puts
$4.62M
Top Buyers
| 1 | +$68.7M | |
| 2 | +$48.7M | |
| 3 | +$32.9M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$31.5M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$22.2M |
Top Sellers
| 1 | -$81.8M | |
| 2 | -$65.9M | |
| 3 | -$52.8M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$50.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28M |